Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Waseda, K. Inuzuka, H. Takato, Y. Ichikawa, M. Yasui, M. Fujimura (Akara-machi, Kanazawa, Heiwa-machi, Kanazawa, Japan). Airway disorders in IgG4-related pulmonary disease. Eur Respir J 2010; 36: Suppl. 54, 1361

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension associated with obliterative phlebitis in IgG4-related lung disease Source: Eur Respir J 2015; 45: 842-845 Year: 2015 Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Bronchial hyperreactivity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 424s Year: 2003 Pulmonary manifestations in adult patients with chronic granulomatous disease Source: Eur Respir J 2015; 45: 1613-1623 Year: 2015 The metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Immunological profiling of chronic obstructive airways disease and idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases. Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Cutaneous vascular spiders are associated with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Epidemiology of COPD and infectious lung diseases Year: 2009 Pulmonary arterial manifestation of systemic inflammation in patients with COPD Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 Inflammation and depression in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 718s Year: 2007 Definition and differential diagnosis of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=1 Year: 2006 Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease Source: International Congress 2014 – Sarcoidosis Year: 2014 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Non-pulmonary comorbidities in idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Central airway stenosis in a patient with autoimmune pancreatitis Source: Eur Respir J 2009; 33: 680-683 Year: 2009 Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Frequency of depressive syndrome in patients with bronchial asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions Year: 2021 Bronchial hyperreactivity in patients with inflammatory bowel disease Source: Eur Respir J 2003; 22: Suppl. 45, 480s Year: 2003